Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $32.03 $45.00 Thursday, 9th May 2024 CRBP stock ended at $43.74. This is 3.18% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 3.47% from a day low at $42.34 to a day high of $43.81.
90 days $20.87 $49.87
52 weeks $3.03 $49.87

Historical Corbus Pharmaceuticals Holdings prices

Date Open High Low Close Volume
Oct 19, 2016 $7.00 $8.00 $6.60 $7.75 2 953 500
Oct 18, 2016 $7.10 $7.45 $6.80 $6.95 1 848 000
Oct 17, 2016 $8.85 $9.00 $6.85 $6.95 2 187 700
Oct 14, 2016 $9.36 $9.50 $8.21 $8.93 1 580 600
Oct 13, 2016 $9.96 $10.00 $8.77 $9.34 1 372 100
Oct 12, 2016 $9.68 $10.15 $9.39 $9.50 1 193 900
Oct 11, 2016 $9.45 $10.12 $9.34 $9.68 1 515 800
Oct 10, 2016 $9.95 $10.78 $9.30 $9.57 3 489 700
Oct 07, 2016 $8.90 $9.95 $8.61 $9.79 2 187 900
Oct 06, 2016 $8.67 $9.73 $8.37 $8.71 3 448 600
Oct 05, 2016 $7.69 $9.78 $7.50 $8.87 13 413 200
Oct 04, 2016 $7.00 $7.03 $6.76 $7.02 523 200
Oct 03, 2016 $6.75 $6.91 $6.57 $6.87 399 800
Sep 30, 2016 $6.52 $6.80 $6.41 $6.79 424 200
Sep 29, 2016 $6.92 $7.18 $6.38 $6.52 743 300
Sep 28, 2016 $6.79 $6.95 $6.39 $6.86 1 137 100
Sep 27, 2016 $6.42 $6.56 $5.90 $6.53 1 130 200
Sep 26, 2016 $6.20 $6.70 $6.20 $6.37 666 000
Sep 23, 2016 $6.92 $6.96 $6.21 $6.25 1 366 200
Sep 22, 2016 $7.49 $7.69 $6.75 $6.98 1 336 500
Sep 21, 2016 $6.95 $7.44 $6.84 $7.42 1 236 700
Sep 20, 2016 $7.40 $7.85 $6.78 $6.97 1 964 200
Sep 19, 2016 $7.22 $7.72 $6.73 $7.57 2 158 200
Sep 16, 2016 $7.10 $7.88 $6.77 $7.14 4 255 200
Sep 15, 2016 $6.48 $7.04 $6.08 $7.02 2 884 800
Click to get the best stock tips daily for free!

About Corbus Pharmaceuticals Holdings

Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibody (mAb) for the treatment of cancer and fibrosis that inhibits the act... CRBP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT